Systematic reviews

Cochrane systematic review

  1. Mao C, Fu XH, Yuan JQ, Yang ZY, Chung VCH, Qin Y, Huang Y, Tam WWS, Kwong JSW, Xie W, Tang JL. Tong-xinluo capsule for patients with coronary heart disease after percutaneous coronary intervention. Cochrane Database Syst Rev 2015; 5: CD010237.
  2. Mao C, Fu XH, Yuan JQ, Yang ZY, Huang YF, Ye QL, Wu XY, Hu XF, Zhai ZM, Tang JL. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission. Cochrane Database Syst Rev. 2015 Nov 6;11:CD010248
  3. Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. Cochrane Database Syst Rev 2014; 11:CD009948.
  4. Mao C, Yang ZYHe BF, Liu S, Zhou JH, Qiu LX, Luo RC, Chen Q, Tang JL. Toremifene versus tamoxifen for advanced breast cancer. Cochrane Database Syst Rev 2012; 7: CD008926.

Other systematic reviews

  1. Mao C, Yang ZY, Hu XF, Chen Q, Tang JL. PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis. Ann Oncol 2012; 23(6):1518-1525.
  2. Yang ZY, Wu XY, Huang YF, Di MY, Zheng DY, Chen JZ, Ding H, Mao C, Tang JL. Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis. Int J Cancer 2013; 133(8):1914-25.
  3. Li BZ, Threapleton DE, Wang JY, Xu JM, Yuan JQ, Zhang C, Li P, Ye QL, Guo B, Mao C, Ye DQ. Comparative effectiveness and safety of therapies for Helicobacter pylori: a systematic review and network meta-analysis. BMJ 2015; 351:h4052.
  4. Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J. Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis. Eur Urol 2013; 63(5):902-12.  
  5. Mao C, Qiu LX, Liao RY, Du FB, Ding H, Yang WC, Li J, Chen Q.KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies. Lung Cancer 2010; 69(3):272-8.
  6. Yang ZY, Shen WX, Hu XF, Zheng DY, Wu XY, Huang YF, Chen JZ, Mao C, Tang JL. EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: meta analysis. J Hematol Oncol 2012; 5(1):52.
  7. Mao C, Qiu LX, Liao RY, Du FB, Ding H, Yang WC, Li J, Chen Q.KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies. Lung Cancer 2010; 69(3):272-8.
  8. Tang JL, Armitage J, Lancaster T, et al. A systematic review of dietary intervention trials on cholesterol lowering in free-living individuals. BMJ 1998; 316(7139): 1213-20. 
  9. Tang JL, Law M, Wald NJ. How effective is nicotine replacement therapy in helping people to stop smoking. BMJ 1994;308(6920): 21-6.
  10. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155(18): 1933-41.